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Abstract
Tumor hypoxia triggers signaling cascades that significantly affect biologic outcomes such as resistance to radio-
therapy and chemotherapy in breast cancer. Hypoxic regions in solid tumor are spatially heterogeneous. Therefore,
delineating the origin and extent of hypoxia in tumors is critical. In this study, we have investigated the effect of
hypoxia on different metabolic pathways, such as lipid and choline metabolism, in a human breast cancer model.
Human MDA-MB-231 breast cancer cells and tumors, which were genetically engineered to express red fluorescent
tdTomato protein under hypoxic conditions, were used to investigate hypoxia. Our data were obtained with a novel
three-dimensional multimodal molecular imaging platform that combines magnetic resonance (MR) imaging, MR
spectroscopic imaging (MRSI), and optical imaging of hypoxia and necrosis. A higher concentration of noninvasively
detected total choline-containing metabolites (tCho) and lipid CH3 localized in the tdTomato-fluorescing hypoxic re-
gions indicated that hypoxia can upregulate tCho and lipid CH3 levels in this breast tumor model. The increase in tCho
under hypoxia was primarily due to elevated phosphocholine levels as shown by in vitro MR spectroscopy. Elevated
lipid CH3 levels detected under hypoxia were caused by an increase in mobile MR-detectable lipid droplets, as dem-
onstrated by Nile Red staining. Our findings demonstrate that noninvasive MRSI can help delineate hypoxic regions in
solid tumors bymeans of detecting the metabolic outcome of tumor hypoxia, which is characterized by elevated tCho
and lipid CH3.
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Introduction
Transcriptional regulation of several genes by hypoxia-inducible
factor 1 (HIF-1) is a well-characterized adaptive response to hypoxia
[1,2]. HIF-1 is a transcriptional master regulator of hypoxia-inducible
genes, many of which promote tumor progression, for example, vas-
cular endothelial growth factor (VEGF) [3] and lysyl oxidase [4].
HIF-1 modulates the transcription of target genes by binding hypoxia
response elements (HREs) containing the consensus binding site 5′-
RCGTG-3′ located within the promoter region of genes. Different
HIF-1–regulated gene products respond to hypoxia differently. Some
of these gene products such as VEGF are largely secreted into the
surrounding stromal matrix and are additionally regulated by multi-
ple other factors in breast cancer, which reduces their specificity as
immunohistochemical markers of hypoxia [3]. Other HIF-1–regulated
genes such as glucose transporter 1 [5] and carbonic anhydrase IX [6] are
localized to the cell of origin and undergo hypoxic regulation that is
predominantly due to HIF-1. HIF-1α, a subunit of the HIF-1 dimer,
is overexpressed in breast cancer, and it promotes tumor progression
[1,2]. HIF-1α is modulated by the oxygen status of the cell such that
it is degraded during normoxia and stabilized during hypoxia [2].
Hypoxia-inducible factor 2α (HIF-2α) is also increased in human
cancers [7]. It has a very similar sequence to HIF-1α, dimerizes with
HIF-1β to form HIF-2, and activates the transcription of a group of
target genes that partially overlaps with but is mostly different from
those regulated by HIF-1 [8]. Hypoxia is one of the hallmarks of
tumors and triggers multiple signaling cascades that significantly affect
biologic outcomes, including angiogenesis, selection for resistance to
apoptosis, resistance to radiation and chemotherapy, and increased in-
vasion and metastasis [9–11]. Hypoxic regions in breast tumors can
have different degrees of severity and can dynamically fluctuate as they
arise from inadequate blood supply and blood vessel collapse, typically
forming a heterogeneous spatial distribution inside of tumors [9,12].
Although cancer cells display a remarkable tolerance to hypoxia,
prolonged and severe hypoxia can eventually result in anoxia, which
can lead to necrotic cell death, a phenomenon seen in many human
tumors including breast cancer [13]. Tumor necrosis has been pro-
posed as a marker of poor prognosis in a variety of solid malignant
tumor types including breast cancer [14–16]. Necrosis of cancer tissue
may be a later consequence of hypoxic cell formation in the pro-
gression of breast cancer. However, the links between necrotic and
hypoxic cells are not yet fully investigated. Expression analysis
of the HIF-1 responsive genes glucose transporter 1 and carbonic
anhydrase IX in 97 breast tumors demonstrated that more than
90% of necrotic and 30% of nonnecrotic tumors expressed at least
one hypoxia marker [17]. Independent assessment of epithelial and
stromal hypoxia can provide new information in terms of prognosis
and patient outcome because stromal hypoxia can improve patient
survival [17]. Therefore, being able to identify the metabolic changes
that cancer cells undergo in hypoxic and necrotic tumor regions
would help to provide a better understanding and evaluation of
hypoxia-triggered signaling pathways in cancer.
In the present study on breast cancer, we have visualized hypoxia
by means of MDA-MB-231-HRE-tdTomato, where the red fluores-
cent protein tdTomato is under the control of an HRE-containing
promoter [18] and thus is conditionally expressed primarily during hyp-
oxia. The tdTomato fluorescence intensity is several-fold more intense
than the enhanced green fluorescent protein fluorescence intensity
[19,20]. Tumoral total choline-containing metabolites (tCho; com-
posed of phosphocholine [PC], glycerophosphocholine [GPC], and free
choline [Cho]) were studied by both in vivo 1H magnetic resonance
(MR) spectroscopic imaging (MRSI) and in vitro high-resolution MR
spectroscopy (MRS). In this tumor model, we also analyzed mobile
lipids, which are lipid droplets containing triglycerides and cholesterol
esters, with MRSI/MRS [21]. Several studies have demonstrated that
these lipids are closely involved in various aspects of tumor biology such
as cell proliferation, necrosis, hypoxia, and drug resistance [22–25].
The spatial distribution of both tCho and mobile lipids, as detected
by MRSI in malignant tumors, is frequently heterogeneous [26]. The
cause of this heterogeneity is largely unknown as molecular analyses of
excised tumor specimens typically report on the entire tumor specimen
or section. Therefore, obtaining MRSI information on the spatial
heterogeneity, especially extending measurements on two-dimensional
tissue sections to three-dimensional tumor volumes, will provide a
better understanding of the spatial distribution of hypoxia-triggered
molecular signaling pathways in the tumor. To understand and evaluate
the complexity as well as the spatial distribution of the hypoxic response
of tumors, we have recently developed a three-dimensional multimodal
molecular imaging platform that combines MR imaging (MRI), MRSI,
and optical imaging of hypoxia and necrosis in breast cancer [27]. Here
we have thoroughly analyzed the tCho and mobile lipid distribution of
eight orthotopic MDA-MB-231-HRE-tdTomato tumor xenografts
using our three-dimensional multimodal molecular imaging platform
and begun to unravel the spatial relationship between hypoxia, necrosis,
and metabolite levels. The detected hypoxia-driven molecular pathways
observed in these in vivo three-dimensional tumor measurements were
confirmed by in vitro studies.
Materials and Methods
Breast Cancer Cells
An estrogen-independent human breast cancer cell line, MDA-
MB-231 [28,29], derived from a metastatic lesion of a breast adeno-
carcinoma in the mammary gland, was obtained from the American
Type Culture Collection (ATCC, Rockville, MD). To generate MDA-
MB-231 cells that express tdTomato under hypoxic conditions as an
internal, HIF-1α–driven hypoxia sensor, MDA-MB-231 cells were sta-
bly transfected with a construct containing HREs of the human VEGF
gene ligated to the complementary DNA of tdTomato, which gener-
atedMDA-MB-231-HRE-tdTomato cells as previously described [18].
MDA-MB-231-HRE-tdTomato cells were cultured in RPMI-1640
(Sigma-Aldrich, St. Louis, MO) supplemented with 10% fetal bovine
serum (Gemini Bio-Products, Woodland, CA), 100 U/ml penicillin,
100 μg/ml streptomycin (Sigma-Aldrich), and 400 μg/ml G418
(Sigma-Aldrich). tdTomato protein expression in normoxic control
and hypoxicMDA-MB-231-HRE-tdTomato cell cultures was detected
by fluorescence microscopy using a 20× objective attached to a Nikon
inverted microscope, equipped with a filter set for 528 to 553 nm
excitation and 600 to 660 nm emission and a Nikon COOLPIX digital
camera (Nikon Instruments, Inc, Melville, NY).
Breast Tumor Xenografts
All experimental animal protocols were approved by the Institu-
tional Animal Care and Use Committee of the Johns Hopkins Uni-
versity School of Medicine. Solid MDA-MB-231-HRE-tdTomato
tumor xenografts were generated by inoculating 2 × 106 MDA-MB-
231-HRE-tdTomato cells in 0.1 ml of Hank balanced salt solution
(Sigma-Aldrich) orthotopically into the left second mammary pad of
female athymic nude mice (catalog no. 01B74; National Cancer Institute,
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Frederick, MD). Tumor xenografts reached their final experimental size
of approximately 8 × 8 × 8 mm3 within 8 weeks, and mice weighed
between 24 and 28 g.
Three-dimensional In Vivo T1-Weighted MRI and MRSI
Tumor-bearing mice were anesthetized by intraperitoneal injection
of ketamine (25 mg/kg; Phoenix Scientific, Inc, Encinitas, CA) and
acepromazine (2.5 mg/kg; Aveco, Phoenix Scientific) diluted in saline
as previously described [27]. All eight mice were scanned in vivo on a
9.4-TBruker Avance Small AnimalMRI Scanner (Bruker, Billerica,MA)
in the Broadway Research Building Molecular Imaging Center at the
Johns Hopkins University School of Medicine. The tumors of anes-
thetized mice were placed inside a home-built 1H solenoid coil mounted
on a plastic cradle with a water-heating pad lying on the bottom to main-
tain the normal body temperature of the animal. A rapid-acquisition-
with-relaxation-enhancement (RARE) spin-echo fast imaging sequence
was used to acquire three-dimensional reference T1-weighted im-
ages. Three-dimensional RARE was performed with the following
parameters: echo time (TE) of 7.2 milliseconds, repetition time of
500 milliseconds, RARE factor of 4, flip angle of 90°, field of view
(FOV) of 1.0 × 1.0 × 1.0 cm, 64-phase encode steps (64 × 64 ×
64 voxels), and number of averages (NA) of 4. Total acquisition time
was 13 minutes. The reconstruction of MRI reference images was
performed using ParaVision 5.0 software (Bruker).
Three-dimensional MRSI data were acquired with a three-
dimensional spin-echo chemical shift imaging (CSI) sequence using
the same coil [30]. Water-suppressed MRSI was performed using
VAPOR on a 1.0 × 1.0 × 1.0-cm FOV enclosing the tumor with the
same geometry as used for the corresponding three-dimensional RARE
acquisition, with an in-plane resolution of 1.25 × 1.25 × 1.25-mm per
pixel and the following parameters: repetition time of 1000 milli-
seconds, TE of 82 milliseconds, sweep width of 4000 Hz, and spectral
resolution 3.9 Hz/point. Standard k-space sampling was used with a
matrix size of 8 × 8 × 8 (zero filled to 64 × 64 × 64) and NA of 4
resulting in a total measurement time of 33 minutes. Corresponding
three-dimensional CSI images of the unsuppressed water signal and
lipids were acquired of the same volume with TE of 15 milliseconds
and NA of 2, and all other parameters remaining the same as for the
water-suppressed MRSI. After these MRI/MRSI studies, mice were
killed, and each tumor was marked with a novel fiducial marker system
[27,31] and cut into 2-mm-thick sections for hypoxia imaging as
described in our previous report [27,31].
Ex Vivo Microscopic Imaging
For microscopic measurements, a given slide holding an embedded,
fiducially marked [31] tumor slice was taken out of the icebox and
placed under the microscope for imaging. In between microscopic mea-
surements, the fresh tumor slices were returned to the icebox to keep
the tissue at 4°C, and they were periodically moistened with saline to
avoid dehydration of the tissue. Both bright-field and fluorescence
microscopy images with the same FOV were obtained using a 1×
objective attached to the Nikonmicroscope described above to visualize
hypoxia. After microscopy, samples were stored in a −80°C freezer until
sets of 10-μm-thick cryosections were cut across the tumor at an inter-
val of 500 μm from top to body wall throughout all 2-mm-thick slices.
The 10-μm sections were stained with hematoxylin and eosin (H&E)
for identification of tumor necrosis and were imaged by the same
microscope with 1× magnification.
Fusion of MRI/MRSI, Optical, and Histologic Imaging
Both water-unsuppressed and water-suppressed MR spectroscopic
images were reconstructed by an in-house IDL program, which per-
formed Fourier transformations over both spatial and spectral axes.
The tCho signal at 3.2 ppm from the water-suppressed MRSI data
(TE = 82 milliseconds) and the lipid CH3 signal at 0.9 ppm from the
water-unsuppressed MRSI data (TE = 15 milliseconds) were used.
The concentration maps of these two metabolite signals were quanti-
fied by normalizing their signals to the water signal in the corre-
sponding water-unsuppressed MRSI data [32].
A previously developed multimodal molecular imaging platform [27]
was applied, which performs fiducial marker-based three-dimensional
reconstruction of optical images, which are then coregistered with
three-dimensional MRI/MRSI. To visualize the tumor boundary and
hypoxic regions, three-dimensional reconstruction of bright-field
and fluorescence images was performed by using this platform [27]
and displayed in Amira 5.2.1 (Mercury Computer Systems, Chelmsford,
MA). Similarly, three-dimensional reconstruction of H&E-stained
images to extract the tumor boundary and necrotic region was com-
pleted [27]. Coregistration of three-dimensional T1-weighted MR
images, three-dimensional optical bright-field/fluorescence images,
and three-dimensional H&E-stained images was also achieved by using
this platform [27].
Quantitative Analysis of MRI/MRSI, Optical,
and Histologic Imaging
Once three-dimensional reconstruction and co-registration was
completed, two different quantification methods, a volume percentage
comparison and the average metabolite concentration for each region,
were applied to the obtained co-registered three-dimensional data sets
to measure the co-localization of the detected metabolites with the
normoxic, hypoxic, and necrotic regions in the tumor. Volume per-
centage was defined as the number of hypoxic voxels that overlap with
a given metabolite normalized to total hypoxic voxels. The volume per-
centage of metabolite overlap with normoxic and necrotic voxels was
calculated analogously. This quantification method depends on the
threshold of signal intensity, which was set to capture tumor regions
of the highest metabolite intensities. To select this threshold, the histo-
gram of a given metabolite image was calculated, and the threshold was
automatically set to include the highest 5% of the area under the histo-
gram. The average metabolite concentrations in normoxic, hypoxic,
and necrotic regions were calculated by averaging all voxel values of a
given metabolite within each of these three regions. In both of these
two quantification methods, the hypoxic region was determined by set-
ting a threshold of the highest 5% of the area under the histogram in
the fluorescence images. The tumor area was determined by edge de-
tection of the tumor boundaries in three-dimensional MRI RARE
images. The necrotic region was also determined by edge detection
of the necrosis boundaries in the H&E-stained images.
Dual-Phase Extraction of Cells
Approximately 108 MDA-MB-231-HRE-tdTomato cells were
exposed for 24 hours to standard normoxic conditions in a regular
incubator (control) or to hypoxic conditions in a hypoxia cell culture
chamber containing PO2 less than 1% (Biospherix, Lacona, NY). As
a third condition, hypoxia was mimicked by treating cells for 24 hours
with 200 μM CoCl2. Cells under control or experimental conditions
were incubated with regular cell culture medium containing all
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Figure 2. (A) Example of a water-suppressed 1H CSI MRSI spectrum from a representative MDA-MB-231-HRE-tdTomato tumor (approxi-
mately 360mm3) obtained with a spatial resolution of 0.9 × 0.9 × 0.8mm showing tCho at 3.2 ppm and lipid CH3 at 0.9 ppm. (B) Example of
a two-dimensional tCho concentration map obtained from the signal at 3.2 ppm in the water-suppressed MRSI data (TE = 82 milliseconds).
(C) Example of a two-dimensional lipid CH3 concentration map obtained from the signal at 0.9 ppm in the water-unsuppressed MRSI data
(TE = 15 milliseconds). Example of (D) a three-dimensional tCho concentration volume (green) and (E) a three-dimensional lipid CH3
concentration volume (cyan) with the tumor boundary shown as a yellow grid.
Figure 1. (A) Diagram depicting the MDA-MB-231-HRE-tdTomato construct, which is activated by HIF-1α stabilization under hypoxic
conditions, whereas HIF-1α is continuously being degraded under normoxic conditions. HIF-1 binds HREs in the HRE-tdTomato con-
struct resulting in tdTomato expression in hypoxic regions, which can be detected by fluorescence microscopy and imaging. (B) Bright-
field (top) and tdTomato fluorescence (bottom) microscopic images (20× lens) of the same FOVs from normoxic (left) and hypoxic (right)
live MDA-MB-231-HRE-tdTomato cells.
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supplements as described above. Treated cancer cells were washed,
centrifuged, and separated into lipid and water-soluble extracts using
a dual-phase extraction method based on methanol/chloroform/water
(1:1:1, vol/vol/vol) as previously described [29,33,34].
MRS Data Acquisition and Processing
The lyophilized water-soluble cell extracts were dissolved in D2O con-
taining the concentration and chemical shift reference 3-(trimethylsilyl)
propionic-2, 2, 3, 3-d4 acid (TSP; Sigma-Aldrich). Lipid cell extracts
were dissolved in 0.6 ml of CDCl3/CD3OD (2:1, vol/vol) containing
tetramethylsilane (TMS) as an internal concentration and chemical
shift standard (CDCl3 and CD3OD were premixed with TMS by
the manufacturer; Cambridge Isotope Laboratories, Inc, Andover,
MA). Fully relaxed 1H MR spectra of the water-soluble and lipid
extracts were acquired on a Bruker Avance 500 nuclear magnetic reso-
nance spectrometer operating at 11.7 T using a 5-mm HX inverse
probe as previously described [29,33]. The Cho peak at 3.209 ppm,
the PC peak at 3.227 ppm, the GPC peak at 3.236 ppm, and the
TSP peak at 0 ppm in the 1H MR spectra of the water-soluble extracts,
and the lipid CH3 peak at 0.9 ppm and the TMS peak at 0 ppm in the
1H MR spectra of the lipid extracts were fitted and integrated by the
software MestRec 4.9 (Mestrelab Research, Escondido, CA) and nor-
malized to the cell number, volume, and the TSP or TMS concentration
standard as previously described [29,33].
Nile Red Staining, Confocal Fluorescence Microscopy, and
Quantitative Image Analysis
MDA-MB-231-HRE-tdTomato cells were exposed to normoxic,
hypoxic, and CoCl2 conditions for 24 hours as described above.
Cells were washed with PBS and incubated with a 1:1000 dilution in
PBS of a 1-mg/ml stock solution of Nile Red (9-diethylamino-5H -
benzo[a]phenoxazine-5-one; Sigma-Aldrich) in acetone for 10 minutes
Figure 3. (A) Example of bright-field and fluorescence images of top, center, and body sections from a representative MDA-MB-231-
HRE-tdTomato tumor (approximately 360 mm3) and the corresponding three-dimensional reconstruction of tumor boundary, fiducial
markers, and tdTomato-fluorescing hypoxic regions. Arrows point out the fiducial markers. (B) H&E-stained images of the same tumor
as shown in A and corresponding three-dimensional reconstruction of necrotic regions and fiducial markers. Arrows point out the fiducial
markers. (C) Overlay of hypoxic (red) and necrotic (blue) regions with MRI tumor boundary (yellow grid) and bright-field tumor boundary
(purple). (D) Overlay of tCho (green), hypoxic (red), and necrotic (blue) regions with tumor boundary. (E) Overlay of lipid CH3 (cyan), hypoxic
(red), and necrotic (blue) regions with tumor boundary.
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at room temperature, which stains lipid droplets [35–37]. Cell nuclei
were counterstained with Hoechst H-33342 (Molecular Probes,
Eugene, OR). Cells were washed and mounted using Faramount
aqueous mounting medium (DakoCytomation, Carpinteria, CA).
Fluorescence microscopy was done with a confocal Zeiss LSM 710
META confocal laser scanning microscope (Carl Zeiss, Inc, Thornwood,
NY) using a Plan-Apochromat 63/1.4 oil immersion lens (Zeiss) in the
Johns Hopkins University School of Medicine Microscope Facility.
Nile Red and H-33342 were excited at 488 and 405 nm, respectively,
and fluorescence emission was detected with photomultipliers in the
range of 550 to 620 nm and 420 to 480 nm, respectively. Confocal
z-stacks of sections were imaged. Twenty-one randomly selected FOVs
of 1-μm thickness containing the maximal number of lipid droplets
were imaged for quantification. Numbers and diameters of lipid drop-
lets per cell were quantified using our in-house Lyso software as previ-
ously described [38]. This Lyso software detected the boundaries of the
nucleus and the lipid droplets in the microscopic confocal fluorescence
images and calculated the center point and effective diameter of each
detected lipid droplet based on the detected boundaries.
Statistical Analysis of Experiments
An unpaired one-tailed t test (α = 0.05) was conducted to detect
significant differences between experimental groups using Excel 2007
(Microsoft Corp, Redmond, WA). P < .05 was considered to be sig-
nificant in the in vitro dual-phase extraction and Nile Red staining
experiments. P < .1 was considered to be significant in the MRSI and
optical imaging experiments.
Results
After exposure of cells to 24 hours of hypoxia (0.3%-0.5%O2), human
MDA-MB-231-HRE-tdTomato cells stably transfected with the HRE-
tdTomato construct (Figure 1A) exhibited bright tdTomato fluorescence
as shown in Figure 1B. Exposure of MDA-MB-231-HRE-tdTomato
cells to normoxic control conditions resulted in undetectable
tdTomato fluorescence signal (Figure 1B). These findings prove that
tdTomato fluorescent protein is only expressed under hypoxic condi-
tion in MDA-MB-231-HRE-tdTomato cells.
To evaluate the relationship between hypoxia and the 1H MRS–
detectable tCho and lipid CH3 signals, eight MDA-MB-231-HRE-
tdTomato breast tumor xenografts were studied by in vivo MRSI in
three dimensions to detect tCho and lipid CH3, followed by ex vivo
optical imaging to detect hypoxia and ex vivoH&E histology imaging
to detect necrosis. A representative CSI MRSI spectrum from an
MDA-MB-231-HRE-tdTomato tumor with tCho at 3.2 ppm and
lipid CH3 at 0.9 ppm is shown in Figure 2A. Representative two-
dimensional tCho and lipid CH3 concentration maps were recon-
structed, and these are displayed in Figure 2, B and C , respectively.
Representative three-dimensional tCho and lipid CH3 concentration
volumes were reconstructed, and these are displayed in Figure 2, D
Figure 4. Average concentration of (A) tCho and (B) lipid CH3 in normoxic (black), hypoxic (gray), and necrotic regions (light gray) in
millimoles per kilogram. Volume percentage of (C) tCho and (D) lipid CH3 in normoxic (black), hypoxic (gray), and necrotic regions (light
gray). Values are mean ± SE. *P < .1, **P < .01. NS indicates not significant.
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and E , respectively. The spatial distributions of both tCho and lipid
CH3 were heterogeneous in this breast tumor model.
After completion of the MRI/MRSI measurements, mice were
killed and tumors removed and sectioned into 2-mm-thick fresh
slices for microscopy. Figure 3A shows an example of bright-field
and fluorescence images of the top, center, and body sections from a
representative MDA-MB-231-HRE-tdTomato tumor and the corre-
sponding three-dimensional reconstruction of the tumor boundary,
fiducial markers, and the tdTomato fluorescence in hypoxic regions.
All MDA-MB-231-HRE-tdTomato tumors displayed a heterogeneous
spatial distribution of hypoxic regions within the tumor. Figure 3B
shows an example of the H&E-stained images from the same tumor
as shown in Figure 3A, and the corresponding three-dimensional recon-
struction of necrotic regions (yellow) and fiducial markers (green).
Figure 3C displays an overlay of the hypoxic (red) and necrotic regions
(blue) with the MRI-derived tumor boundary (yellow grid) and the
bright-field-derived tumor boundary (purple). The necrotic region
in this tumor is adjacent to the hypoxic region in the center of the
tumor, indicating that an extreme lack of oxygen leads to cell death.
Figure 3D shows an overlay of tCho (green), hypoxic regions (red),
and necrotic regions (blue) including the tumor boundary obtained
after application of our coregistration and three-dimensional re-
construction platform. Figure 3E displays an overlay of lipid CH3
(cyan), hypoxic regions (red), and necrotic regions (blue) including
the tumor boundary.
The quantification of overlaps of hypoxic or necrotic regions with
tCho or lipid CH3 was compared to the overlaps of normoxic regions
with tCho or lipid CH3 in eight MDA-MB-231-HRE-tdTomato
breast tumors, all of which contained hypoxic regions and four of
which contained necrotic regions. Figure 4A illustrates the average
concentration of tCho in normoxic, hypoxic, and necrotic regions.
The average concentration of tCho in the normoxic regions was sig-
nificantly (P = .01, n = 8 for comparison between hypoxia and nor-
moxia; P = .04, n = 4 for comparison between hypoxia and necrosis)
lower than that in the hypoxic and necrotic regions. The average con-
centration of lipid CH3 was significantly (P = .08, n = 8 for compar-
ison between hypoxia and normoxia; P = .07, n = 4 for comparison
between hypoxia and necrosis) higher in hypoxic regions than that in
normoxic and necrotic regions (Figure 4B). Figure 4C presents the
volume percentage of tCho in hypoxic, normoxic, and necrotic regions.
The volume percentage of tCho in the hypoxic and necrotic regions was
significantly (P = .0006, n = 8 for comparison between hypoxia and
normoxia; P = .006, n = 4 for comparison between necrosis and nor-
moxia) higher than that in the normoxic regions, whereas the volume
percentage of tCho in hypoxic regions was significantly higher than that
in necrotic regions (P = .09, n = 4). Similarly, the volume percentage of
lipid CH3 was higher in hypoxic and necrotic regions compared with
that in normoxic regions (P = .01, n = 8 for comparison between hyp-
oxia and normoxia; P = .02, n = 4 for comparison between necrosis and
normoxia), whereas the volume percentage of lipid CH3 was higher in
Figure 5. Expanded regions of representative high-resolution 1H MR spectra of MDA-MB-231-HRE-tdTomato breast cancer cell extracts
after 24 hours of (A) normoxia or (B) hypoxia. Both samples are from approximately 3 × 107 cells. (C) Average concentration of GPC, PC,
PC/GPC, tCho, and lipid CH3 quantified from 1H MR spectra obtained from MDA-MB-231-HRE-tdTomato cells exposed to normoxic
control conditions, hypoxia, or CoCl2. Values are mean ± SE. *P < .05, **P < .01.
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hypoxic than in necrotic regions (P = .05, n = 4; Figure 4D). In sum-
mary, our results showed that the highest-volume percentages and the
highest concentrations of tCho and lipid CH3 were detected in hypoxic
regions of breast tumor xenografts.
To further examine if hypoxia can increase both tCho and lipid
CH3 levels, we measured cellular PC, GPC, and tCho levels in hyp-
oxic versus normoxic MDA-MB-231-HRE-tdTomato cells in culture
by using high-resolution 1H MRS. Figure 5, A and B, presents repre-
sentative 1H MRS spectra after hypoxic and normoxic exposure,
respectively. Figure 5C shows the quantification analysis of these
high-resolution 1H MRS measurements, indicating that PC (P =
.008, n = 6) as well as tCho (P = .008, n = 6) significantly increased
after hypoxic exposure compared with normoxic controls. Lipid CH3
also increased after hypoxia compared to normoxia (P = .008, n = 6).
Similarly, CoCl2-treated cells, in which hypoxia was mimicked by
CoCl2, showed significantly higher PC (P = .04, n = 6), tCho (P =
.05, n = 6), and lipid CH3 (P = .01, n = 6) levels in these cell culture
experiments (Figure 5C).
Figure 6, A to C , shows three-dimensional confocal microscopic
z-stack images of Nile Red–stained MDA-MB-231-HRE-tdTomato
cells after 24 hours of normoxic, hypoxic, and CoCl2 exposure. Both
average diameter and average number of lipid droplets in 21 randomly
selected FOVs were calculated by our in-house software. Figure 6D
demonstrates that the average diameters of lipid droplets were in-
creased in hypoxic and CoCl2 exposed cells compared with normoxic
control cells (P = .025, n = 21 for comparison between CoCl2 and
normoxia; P = .0002, n = 21 for comparison between hypoxia and
normoxia). Figure 6E shows that the average number of lipid droplets
was increased in hypoxic- and CoCl2-exposed cells compared with
normoxic control cells (P = .019, n = 21 for comparison between
CoCl2 and normoxia; P = .0008, n = 21 for comparison between
hypoxia and normoxia).
Discussion
Volume percentages and concentrations of tCho and lipid CH3 sig-
nificantly increased in hypoxic breast tumor regions compared with
normoxic regions, as determined by our three-dimensional multi-
modal molecular imaging platform and quantification. The increase
in tCho was due to a hypoxia-induced increase in PC as shown in our
cell culture experiments. These findings are in good agreement with
our previous study, which showed that choline kinase α (Chk-α)
expression is regulated by means of HIF-1 binding to the Chk-α
promoter in prostate cancer cells [26]. This study suggested that
the putative Chk-α promoter region contains at least six HREs and
that HIF-1 binding of these HREs can increase Chk-α expression
within hypoxic environments, consequently increasing cellular PC
and tCho levels within these environments [26]. However, it is not
clear if all of the HREs in the putative Chk-α promoter region are
involved in upregulating Chk-α expression within hypoxic environ-
ments because HRE-7 may be involved in transcriptional down-
regulation of Chk-α as indicated by mutation studies [39]. Necrotic
tumor regions also contained elevated tCho levels in our study, which
was most likely due to persisting elevated tCho levels from previous
severe hypoxia in these regions.
Figure 6. Three-dimensional confocal microscopic z-stack images of Nile Red–stained MDA-MB-231-HRE-tdTomato breast cancer cells
after 24 hours of (A) normoxia, (B) hypoxia, and (C) CoCl2 exposure. (D) Average diameter and (E) average number of lipid droplets after
24 hours of normoxia, hypoxia, or CoCl2 exposure. Quantitative analysis was performed from 21 randomly selected FOVs. Values are
mean ± SE. *P < .05, **P < .01.
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Our finding of increased lipid droplets leading to an increased lipid
CH3 signal in hypoxic and necrotic breast tumor regions is in good
agreement with a study in rodent brain tumors, which attributed
the presence of mobile lipids in viable cells primarily to the ex-
istence of hypoxic regions adjacent to necrotic areas [22]. In this
study, lipid droplets were located in necrotic tumor regions, and
severely hypoxic cells accumulated small lipid droplets in C6 rat
brain gliomas [22]. We showed that the highest lipid CH3 levels
were found in hypoxic regions of MDA-MB-231-HRE-tdTomato
tumors, whereas necrotic regions contained less lipid CH3, making
lipid CH3 a good marker of hypoxic regions. In addition, we de-
tected an increase in the volume percentage of lipid CH3 in ne-
crotic regions compared to control, which probably stems from a
gradual transition of severely hypoxic regions to necrotic tissue. This
necrotic tissue then still contains some of the metabolites that were pro-
duced, while the cells underwent a period of severe hypoxia before
undergoing necrotic cell death. The increased volume percentage of
lipid CH3 in necrotic regions of our breast tumor model is in good
agreement with comparable data obtained in human brain tumors [25].
Hypoxic regions of breast tumors have long proven to be resilient
and unresponsive to both radiotherapy and chemotherapy [40]. Such
resistance to treatment contributes to the incidence of cancer recur-
rence [40]. Our results indicate that three-dimensional MRSI de-
tection of tCho and lipid CH3 and its heterogeneity might prove
useful as biomarkers not only of breast tumor aggressiveness and pro-
gression but also of tumor hypoxia, which is consistent with our pre-
vious two-dimensional MRSI report in a prostate cancer model [26].
Although we observed that elevated tCho and lipid CH3 overlapped
with a large portion of hypoxic regions, regions of high tCho and lipid
CH3 without fluorescence were also occasionally observed. The latter
indicates that factors other than hypoxia may have also contributed to
the spatial heterogeneity of the tumoral tCho and lipid CH3 levels.
Effects of such other factors and conditions of the tumor microenviron-
ment, such as acidic extracellular pH and nutrient deprivation, stromal
cell contributions, and contributions from extracellular matrix com-
ponents, should be further investigated in the future. In addition, the
relatively long half-life of the tdTomato fluorescent protein in our
hypoxia model may have limitations in representing the dynamic fluc-
tuating nature of tumor hypoxia.
Visualizing the spatial distribution of MR-visible tCho and lipids in
three dimensions could also be useful for monitoring treatment re-
sponse. For example, tCho and lipids were mapped in a rat brain con-
taining a herpes simplex virus thymidine kinase–positive BT4C glioma
undergoing apoptosis-inducing ganciclovir treatment [41]. Spatially dis-
tinct changes of both signals were observed on day 8 of treatment with
an increased mobile lipid concentration and decreased tCho levels [41].
Because of the broader line widths that result from magnetic field
inhomogeneities in in vivo MRSI, it is currently not possible to re-
solve Cho, PC, and GPC, even at the highest available magnetic field
strengths. As a result, in this study, only tCho and lipid CH3 were
observed. To study more biomolecules, such as lipids, proteins, and
peptides, which showed an altered expression or content under hypoxic
conditions or necrosis, it may be helpful in future studies to use an
approach that combines ex vivo mass spectrometry (MS) with in vivo
MS imaging [42,43]. Additional sections that were cut adjacent to the
H&E-stained sections can be used to perform MS imaging, and our
multimodal molecular imaging platform, in the future, can be adapted
for studying altered biomolecules in hypoxic and necrotic regions in
breast cancers.
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